Prothena Corp. Plc Stock Chart

Prothena Corp. Plc (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Prothena Corp. Plc

LSE
Market Cap
$533.99M
Shares Out.
53.83M
Sector
Health Technology
Industry
Biotechnology

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

www.prothena.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free